Exploring how a new receptor affects CAR-T cell effectiveness in treating lymphoma
Investigating a Novel Inhibitory Receptor in Regulating CAR-T Cell Persistence and Function
This study is looking at a special receptor that might make CAR-T cell therapy for lymphoma less effective, and it aims to see if blocking this receptor can help these immune cells work better in both mice and people.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10947466 on NIH RePORTER |
What this research studies
This research investigates the role of a specific inhibitory receptor that may limit the effectiveness and longevity of CAR-T cells, a type of immunotherapy used to treat lymphoma. The study will first assess how this receptor impacts the performance of CAR-T cells in mouse models. Following this, the research will analyze the presence of this receptor in human CAR-T cells and evaluate whether blocking it can enhance their function. The findings aim to improve CAR-T cell therapies, potentially leading to better outcomes for patients with lymphoma.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with lymphoma who are considering or have undergone CAR-T cell therapy.
Not a fit: Patients with other types of cancer or those who are not eligible for CAR-T cell therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective CAR-T cell therapies, reducing relapse rates in lymphoma patients.
How similar studies have performed: Previous research has shown promise in enhancing CAR-T cell therapies by targeting inhibitory receptors, indicating a potential for success in this approach.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Wang, Li Lily — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Wang, Li Lily
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.